Patent Expiry

Patent/Exclusivity Expiry: PEMFEXY

Other upcoming events for IOVA

Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multicenter, Randomized, Open-label, Parallel Group, Treatment Study to Assess the Effica
Patent ExpiryPatent/Exclusivity Expiry: PEMETREXED

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: PEMFEXY — IOVA Patent Expiry | BioSniper